1.09
price up icon0.93%   0.01
after-market アフターアワーズ: 1.09
loading
前日終値:
$1.08
開ける:
$1.1
24時間の取引高:
307.55K
Relative Volume:
0.57
時価総額:
$67.49M
収益:
$248.00K
当期純損益:
$-113.22M
株価収益率:
-0.5919
EPS:
-1.8416
ネットキャッシュフロー:
$-98.81M
1週間 パフォーマンス:
-5.22%
1か月 パフォーマンス:
-3.54%
6か月 パフォーマンス:
-16.15%
1年 パフォーマンス:
-31.45%
1日の値動き範囲:
Value
$1.07
$1.105
1週間の範囲:
Value
$1.05
$1.145
52週間の値動き範囲:
Value
$1.05
$1.95

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
名前
Pliant Therapeutics Inc
Name
セクター
Healthcare (1071)
Name
電話
650-481-6770
Name
住所
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
職員
49
Name
Twitter
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
PLRX's Discussions on Twitter

Compare PLRX vs VRTX, REGN, ARGX, RVMD, ALNY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PLRX icon
PLRX
Pliant Therapeutics Inc
1.09 67.49M 248.00K -113.22M -98.81M -1.8416
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
477.36 121.16B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
656.01 68.78B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
918.22 57.44B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
189.23 40.23B 742.00K -1.37B -1.07B -7.0731
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
271.77 36.28B 4.29B 577.22M 641.34M 4.2086

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 ダウングレード JP Morgan Neutral → Underweight
2025-03-04 再開されました Cantor Fitzgerald Neutral
2025-03-04 ダウングレード Needham Buy → Hold
2025-03-03 ダウングレード Leerink Partners Outperform → Market Perform
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-10 ダウングレード Canaccord Genuity Buy → Hold
2025-02-10 ダウングレード Citigroup Buy → Neutral
2025-02-10 ダウングレード H.C. Wainwright Buy → Neutral
2025-02-10 ダウングレード JP Morgan Overweight → Neutral
2025-02-10 ダウングレード Oppenheimer Outperform → Perform
2025-02-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-10 ダウングレード Wells Fargo Overweight → Equal Weight
2024-09-09 再開されました Leerink Partners Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-05-18 開始されました Canaccord Genuity Buy
2023-04-13 開始されました Robert W. Baird Outperform
2022-12-14 開始されました Stifel Buy
2022-12-07 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Buy
2022-07-20 開始されました SVB Leerink Outperform
2022-05-25 開始されました Cantor Fitzgerald Overweight
2021-12-10 開始されました Oppenheimer Outperform
2021-11-24 開始されました RBC Capital Mkts Outperform
2021-11-03 開始されました H.C. Wainwright Buy
2021-04-20 開始されました BTIG Research Buy
2021-04-05 開始されました Citigroup Buy
2020-06-29 開始されました Citigroup Buy
2020-06-29 開始されました Cowen Outperform
2020-06-29 開始されました Needham Buy
2020-06-29 開始されました Piper Sandler Overweight
すべてを表示

Pliant Therapeutics Inc (PLRX) 最新ニュース

pulisher
Jul 25, 2026

Pliant Therapeutics Inc (PLRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PLRX|Pliant Therapeutics Inc|Price:1.090|Chg%:+0.010 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Pliant Therapeutics Inc (PLRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Pliant Therapeutics Inc (PLRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics, Inc. Files Form 8-K with SEC Detailing Company Information and NASDAQ Listing - Minichart

Jul 13, 2026
pulisher
Jul 13, 2026

Form 4 Pliant Therapeutics Inc For: 13 July By Investing.com - Investing.com Nigeria

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics adds independent directors to strengthen R&D - TipRanks

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics (PLRX) director Robert Iannone submits initial Form 3 - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics (PLRX) director files initial insider ownership statement - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics (PLRX) awards 60,000 stock options to director Flavia Borellini - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

[8-K] PLIANT THERAPEUTICS, INC. Reports Material Event - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics adds two directors with oncology expertise - Investing.com UK

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics appoints Flavia Borellini to board, strengthening executive leadership - Traders Union

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics adds two directors with oncology expertise By Investing.com - Investing.com Nigeria

Jul 13, 2026
pulisher
Jul 13, 2026

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors - The Manila Times

Jul 13, 2026
pulisher
Jul 11, 2026

Price to sales forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView

Jul 11, 2026
pulisher
Jul 11, 2026

Price to earnings forward of Pliant Therapeutics, Inc. – FWB:9PT - TradingView

Jul 11, 2026
pulisher
Jul 11, 2026

Price to book forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView

Jul 11, 2026
pulisher
Jul 10, 2026

Enterprise value to revenue forward of Pliant Therapeutics, Inc. – FWB:9PT - TradingView

Jul 10, 2026
pulisher
Jul 10, 2026

Enterprise value to revenue forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView

Jul 10, 2026
pulisher
Jul 09, 2026

Price to earnings forward of Pliant Therapeutics, Inc. – TRADEGATE:9PT - TradingView

Jul 09, 2026
pulisher
Jul 09, 2026

Pliant Therapeutics (PLRX) Stock Edges Lower, Holds Closely Above Key SupportAccumulation Line - dars.gov.et

Jul 09, 2026
pulisher
Jul 08, 2026

Pliant Therapeutics (PLRX) Holds Steady at $1.17 as Traders Eye Key Support and Resistance LevelsVolume Dry Up - dars.gov.et

Jul 08, 2026
pulisher
Jul 05, 2026

Enterprise value to EBITDA forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX - TradingView

Jul 05, 2026
pulisher
Jul 05, 2026

Enterprise value to EBITDA forward of Pliant Therapeutics, Inc. – GETTEX:9PT - TradingView

Jul 05, 2026
pulisher
Jul 03, 2026

Pliant Therapeutics Inc. (PLRX) Q1 2026 Earnings: Narrower Loss Sends Stock HigherTech Earnings Analysis - dars.gov.et

Jul 03, 2026
pulisher
Jul 01, 2026

Pliant Therapeutics (PLRX) Edges Higher Amid Consolidation Near SupportPre-Earnings Momentum - dars.gov.et

Jul 01, 2026
pulisher
Jun 30, 2026

Pliant Therapeutics Inc. (PLRX) Q1 2026 Earnings: EPS Beat Highlights Cost DisciplineSegment Revenue Breakdown - dars.gov.et

Jun 30, 2026
pulisher
Jun 29, 2026

PLRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 29, 2026
pulisher
Jun 28, 2026

Pliant Therapeutics (PLRX) Inches Higher Amid Ongoing Volatility: Key Levels to WatchMerger Arbitrage - dars.gov.et

Jun 28, 2026
pulisher
Jun 26, 2026

Pliant Therapeutics Inc (PLRX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 26, 2026
pulisher
Jun 25, 2026

9PT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Pliant Therapeutics, Inc. Actuals & Estimates (NASDAQ:PLRX) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

PLRX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Pliant Therapeutics (PLRX) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress ContinuesManagement Guidance Update - DonanımHaber

Jun 24, 2026
pulisher
Jun 23, 2026

Pliant Therapeutics Inc (PLRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 17, 2026

Pliant Therapeutics Inc (PLRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Pliant Therapeutics Inc (PLRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Pliant Therapeutics Inc (PLRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Pliant Therapeutics Inc (PLRX) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 13, 2026

PLRX SEC FilingsPliant Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 13, 2026
pulisher
Jun 12, 2026

Pliant Therapeutics (PLRX) director receives 70,000 stock options at $1.14 - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Pliant Therapeutics (PLRX) director granted 70,000 options at $1.14 strike - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Pliant Therapeutics (PLRX) director receives 70,000-share stock option grant - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Pliant (NASDAQ: PLRX) director awarded 70,000 stock options at $1.14 - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

PLIANT THERAPEUTICS (PLRX) director granted 70,000 stock options at $1.14 - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Director Darren Cline receives 70,000 PLRX stock options at $1.14 strike price - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Pliant Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huh Hoyoung - Moomoo

Jun 12, 2026
pulisher
Jun 11, 2026

Pliant Therapeutics Shareholders Approve Directors and Executive Pay - TipRanks

Jun 11, 2026
pulisher
Jun 11, 2026

Pliant Therapeutics (NASDAQ: PLRX) reports 2026 director, pay and auditor votes - Stock Titan

Jun 11, 2026
pulisher
Jun 05, 2026

PLIANT THERAPEUTICS INC (PLRX) Stock Chart - ChartMill

Jun 05, 2026

Pliant Therapeutics Inc (PLRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$106.92
price down icon 0.46%
$117.67
price up icon 0.84%
$35.01
price down icon 0.26%
$58.83
price down icon 0.32%
ONC ONC
$325.90
price down icon 0.27%
$271.77
price up icon 1.13%
大文字化:     |  ボリューム (24 時間):